Literature DB >> 17065921

Inflammatory mediators of uveitis: cytokines and chemokines.

S John Curnow1, Philip I Murray.   

Abstract

PURPOSE OF REVIEW: The study of uveitis has been restricted by the difficulty in obtaining sufficient intraocular material from both human disease and experimental models. Recent developments in cytokine and chemokine detection have overcome many of these problems. This review presents a summary of the technologic advances in this area. RECENT
FINDINGS: Recent advances in cytokine analysis, in particular multiplexed bead immunoassays, have allowed the measurement of an extensive array of cytokines and chemokines from very small sample volumes. This has revolutionized uveitis research, enabling measurement of a large profile of cytokines and chemokines in intraocular fluid, such as aqueous humour. This allows us to recognize complex patterns of cytokines and chemokines from different forms of uveitis and to examine relationships between different molecules.
SUMMARY: The spectrum of proinflammatory cytokines and chemokines known to be implicated in uveitis has increased over recent years. Many of these molecules have also been found in experimental models of disease and may represent attractive therapeutic targets for the future. With recent advances in cytokine detection, an extension of these techniques with a more detailed analysis of different uveitis conditions may provide useful diagnostic and prognostic information for this potentially blinding group of diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17065921     DOI: 10.1097/ICU.0b013e32801094b5

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  31 in total

1.  Prevention of endotoxin-induced uveitis in rats by plant sterol guggulsterone.

Authors:  Nilesh M Kalariya; Mohammad Shoeb; Aramati B M Reddy; Min Zhang; Frederik J G M van Kuijk; Kota V Ramana
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-04-30       Impact factor: 4.799

2.  Inflammatory cytokines in eyes with uveal melanoma and relation with macrophage infiltration.

Authors:  Long V Ly; Inge H G Bronkhorst; Els van Beelen; Johannes Vrolijk; Andrew W Taylor; Mieke Versluis; Gregorius P M Luyten; Martine J Jager
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-06-10       Impact factor: 4.799

3.  Cytokines in uveitis.

Authors:  J A M van Laar; P M van Hagen
Journal:  Clin Med Res       Date:  2006-12

4.  Ocular immune privilege in the year 2010: ocular immune privilege and uveitis.

Authors:  Andrew W Taylor; Henry J Kaplan
Journal:  Ocul Immunol Inflamm       Date:  2010-12       Impact factor: 3.070

Review 5.  Advances in the diagnosis and immunotherapy for ocular inflammatory disease.

Authors:  Steven Yeh; Lisa J Faia; Robert B Nussenblatt
Journal:  Semin Immunopathol       Date:  2008-03-05       Impact factor: 9.623

6.  Bacillus cereus-induced permeability of the blood-ocular barrier during experimental endophthalmitis.

Authors:  Andrea L Moyer; Raniyah T Ramadan; Billy D Novosad; Roger Astley; Michelle C Callegan
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-03-05       Impact factor: 4.799

7.  Zoledronic acid induced unilateral anterior uveitis.

Authors:  Shipra Gupta; Abhishek Onkar; Tushar Vashisht
Journal:  Indian J Ophthalmol       Date:  2020-09       Impact factor: 1.848

8.  Expressions of lymphotactin and its receptor, XCR, in Lewis rats with experimental autoimmune anterior uveitis.

Authors:  Po-Ting Yeh; Feng-An Lin; Chang-Pin Lin; Chung-May Yang; Muh-Shy Chen; Chang-Hao Yang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-06-29       Impact factor: 3.117

9.  Anti-TNF-α agents for refractory cystoid macular edema associated with noninfectious uveitis.

Authors:  Michal Schaap-Fogler; Radgonde Amer; Ronit Friling; Ethan Priel; Michal Kramer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-12-24       Impact factor: 3.117

10.  Aldose reductase inhibition prevents endotoxin-induced uveitis in rats.

Authors:  Umesh C S Yadav; Satish K Srivastava; Kota V Ramana
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-10       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.